Table 2. Univariate analyses for variables at recurrence.
Variables | Number | Median survival (months) | P-value |
---|---|---|---|
Age at recurrence (years) | |||
<50 | 17 | 29 | |
⩾50 | 27 | 40 | 0.860 |
Disease-free interval (months) | |||
⩾12 | 31 | 47 | |
<12 | 13 | 23 | 0.002 |
Intraperitoneal tumour | |||
Absent | 12 | 64 | |
Present | 32 | 27 | 0.117 |
Pelvic or aortic lymph node metastases | |||
Absent | 34 | 32 | |
Present | 10 | 37 | 0.419 |
Distant metastasis | |||
Absent | 38 | 32 | |
Present | 6 | 40 | 0.496 |
Liver metastasis | |||
Absent | 42 | 33 | |
Present | 2 | 20 | 0.005 |
No. of recurrent tumours | |||
Solitary | 16 | 64 | |
Multiple | 28 | 27 | 0.007 |
Size of maximum tumour (cm) | |||
<6 | 38 | 40 | |
⩾6 | 6 | 14 | <0.001 |
Massive ascites (>500 ml) | |||
Absent | 41 | 33 | |
Present | 3 | 32 | 0.318 |
PS | |||
0–2 | 42 | 29 | |
3 | 2 | 42 | 0.746 |
Presurgical chemotherapy | |||
Not done | 23 | 33 | |
Done | 21 | 29 | 0.677 |
Bowel resection | |||
Not done | 33 | 33 | |
Done | 11 | 27 | 0.650 |
Residual tumour at SCS | |||
0 | 26 | 52 | |
Any | 18 | 22 | 0.002 |
PS=performance status; SCS=secondary cytoreductive surgery.